ARCHIVES

Gemcitabine Improves DFS In Resected Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Four RFAs Released For RM Program

November 6, 1981

FDA News: Agency Accepting Nominations For Patient Representatives

May 8, 1998

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

In Brief: NCAB To Hear Report On Controversial Special Virus Cancer Program March 19; Centers, Bladder Project Also On Agenda

March 8, 1974

Six Surgical Oncology Grants To Be Funded

June 8, 1984

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011